2 completed, 2 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Patrick Joseph Loehrer Sr.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) Lonsurf, Gemcitabine, Nab-Paclitaxel - Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1 | Terminated | Patrick Joseph Loehrer Sr. | 14 | 2019-09-11 | 2024-01-05 |
| Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma Cabozantinib 40 MG, Erlotinib 100Mg Tab - Pancreatic Adenocarcinoma Metastatic | Phase 2 | Terminated | Patrick Joseph Loehrer Sr. | 7 | 2017-10-13 | 2020-08-27 |
| A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas BKM120 - Thymoma | Phase 2 | Completed | Patrick Joseph Loehrer Sr. | 14 | 2014-10-01 | 2022-04-11 |
| Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas Metastatic Pancreatic Cancer | Withdrawn | Patrick Joseph Loehrer Sr. | 2014-07-01 | 2019-07-10 | ||
| Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma Premetrexed (Alimta) - Thymoma, Thymic Carcinoma | Phase 2 | Completed | Patrick Joseph Loehrer Sr. | 27 | 2005-01-01 | 2019-07-22 |
Pancreatic Neoplasms (2) · Thymoma (2)
130-nm albumin-bound paclitaxel (1) · Erlotinib Hydrochloride (1) · Gemcitabine (1) · NVP-BKM120 (1) · Pemetrexed (1) · cabozantinib (1) · trifluridine tipiracil drug combination (1)
United States (4)
Patrick Loehrer, M.D. (2) · Bert H. O'Neil, MD (1) · Bert O'Neil, MD (1) · Patrick J Loehrer, MD (1)